Last synced on 2 May 2025 at 11:05 pm

IVOBASE HYBRID, IVOBASE HIGH IMPACT

Page Type
Cleared 510(K)
PDF
FDA Hosted PDF
* The FDA doesn't provide PDFs for all submissions.
510(k) Number
K103391
510(k) Type
Traditional
Applicant
IVOCLAR VIVADENT, INC.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
2/17/2011
Days to Decision
90 days
Submission Type
Statement

IVOBASE HYBRID, IVOBASE HIGH IMPACT

Page Type
Cleared 510(K)
PDF
FDA Hosted PDF
* The FDA doesn't provide PDFs for all submissions.
510(k) Number
K103391
510(k) Type
Traditional
Applicant
IVOCLAR VIVADENT, INC.
Country
United States
FDA Decision
Substantially Equivalent
Decision Date
2/17/2011
Days to Decision
90 days
Submission Type
Statement